N/a
-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-Intraday pattern: Bowl
-Levels: 28.50, 30, 30.50
First test long of 30 level with whole dollar, VWAP and prior close confluence
OGT, noticed all the confluence factors and got to full size, scaled out on the pop.
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-03-30 14:59:12 | MRNA | buy | $30.220 | long |
2020-03-30 14:59:14 | MRNA | buy | $30.200 | long |
2020-03-30 14:59:16 | MRNA | buy | $30.100 | long |
2020-03-30 14:59:35 | MRNA | buy | $30.150 | long |
2020-03-30 15:00:25 | MRNA | sell | $30.330 | long |
2020-03-30 15:02:32 | MRNA | sell | $30.340 | long |
2020-03-30 15:02:36 | MRNA | sell | $30.320 | long |
2020-03-30 15:02:48 | MRNA | sell | $30.310 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!